Syneron Medical Ltd (ELOS)
11.00 unch (unch) 07/17/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 179 | -6,340 | -5,200 | 1,547 | N/A |
| Depreciation Amortization | 8,447 | 8,965 | 8,283 | 10,472 | N/A |
| Income taxes - deferred | 2,751 | 957 | -976 | -3,386 | N/A |
| Accounts receivable | -4,496 | -3,609 | -2,634 | -8,629 | N/A |
| Accounts payable and accrued liabilities | 446 | 921 | 3,994 | 2,236 | N/A |
| Other Working Capital | -12,358 | -15,312 | 5,081 | -31,344 | N/A |
| Other Operating Activity | 13,391 | 11,590 | 7,565 | 7,152 | 0 |
| Operating Cash Flow | $8,360 | $-2,828 | $16,113 | $-21,952 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,062 | 21,119 | 17,965 | -2,480 | N/A |
| PPE Investments | -3,699 | -4,870 | -2,751 | -3,661 | N/A |
| Net Acquisitions | 4,307 | N/A | -11,016 | -320 | N/A |
| Purchase Sale Intangibles | -150 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -175 | -25 | -9 | -366 | 0 |
| Investing Cash Flow | $-2,629 | $16,224 | $4,189 | $-6,827 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,125 | 1,525 | 7,232 | N/A |
| Common Stock Repurchased | -3,925 | -15,590 | -485 | N/A | N/A |
| Other Financing Activity | -1,088 | 0 | 0 | -5,156 | 0 |
| Financing Cash Flow | $-5,013 | $-13,465 | $1,040 | $2,076 | $N/A |
| Exchange Rate Effect | -292 | -790 | -1,736 | -2,073 | N/A |
| Beginning Cash Position | 56,330 | 57,189 | 37,583 | 66,359 | N/A |
| End Cash Position | 56,756 | 56,330 | 57,189 | 37,583 | N/A |
| Net Cash Flow | $426 | $-859 | $19,606 | $-28,776 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,360 | -2,828 | 16,113 | -21,952 | N/A |
| Capital Expenditure | -3,699 | -4,870 | -2,751 | -3,661 | N/A |
| Free Cash Flow | 4,661 | -7,698 | 13,362 | -25,613 | 0 |